Merck KGaA (OTCMKTS:MKGAF - Get Free Report)'s stock price was down 5.3% during mid-day trading on Monday . The company traded as low as $126.18 and last traded at $126.18. Approximately 24 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 1,055 shares. The stock had previously closed at $133.25.
Merck KGaA Price Performance
The stock has a market cap of $17.21 billion, a P/E ratio of 20.33 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The business has a 50 day simple moving average of $130.33 and a 200-day simple moving average of $135.24.
About Merck KGaA
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
